New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
11
441

Dermatology

for medical students: what you need to know, from skin basics to treatment in psoriasis and melanoma, managing uncertainty  
catherine hyde
almost 7 years ago
Preview 300x425
7
78

Stem cell markers in human uveal melanoma

Uveal melanoma is a rare but very aggressive malignancy: independently of the currently available therapies, 50 % of patients will develop metastasis and median survival time of these patients is only less than 8 months.  
Zoltán Cserháti
over 6 years ago
Preview
1
26

Skin Cancer

Skin cancer is the most common malignancy – and the incidence is increasing rapidly In the last 10 years, the incidence in the UK has doubled Responsible for 2% of cancer deaths each year 80% of these are melanoma   General Risk Factors Age Sun bed use Fair skin Hx of sunburn Hx of living overseas FH Occupations – outdoors – e.g. bricklayer  
almostadoctor.com - free medical student revision notes
over 5 years ago
Preview
1
28

Warning over sunbeds as melanoma cases increase - BBC News

A report warns that continued use of sunbeds could be a key factor in a sharp increase in the rate of skin cancer in Scotland.  
BBC News
over 5 years ago
Www.bmj
1
18

Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis

Data sources PubMed, ISI Web of Science (Science Citation Index Expanded), Embase, Pascal, Cochrane Library, LILACS, and MedCarib, along with published surveys reporting prevalence of sunbed use at national level in Europe.  
bmj.com
over 4 years ago
Preview
1
14

First drug is approved under scheme that gives patients access to unlicensed medicines

The first drug to be made available to patients in the United Kingdom before it is formally licensed will be pembrolizumab, a treatment for advanced melanoma.  
bmj.com
over 4 years ago
Preview
1
18

First drug is approved under scheme that gives patients access to unlicensed medicines

The first drug to be made available to patients in the United Kingdom before it is formally licensed will be pembrolizumab, a treatment for advanced melanoma.  
bmj.com
over 4 years ago
11
0
17

Risk Factor of BRCA1 with family history.

Risk Factor of BRCA1 with family history. First degree relatives - A male in one family dies of peritoneal cancer - aged 49, a sister carries the BRCA1 gene and has been diagnosed with triple negative breast cancer aged 45. Father diagnosed with melanoma, 3 sisters with mutliple cases of BCC & SCC skin cancers. Patenal Side - Grandmother died of breast cancer aged 42. (no other details known on paternal side of family) Maternal side - Aunt dies of non hodgkin's lymphoma in her early 30's. Uncle dies of bowel cancer in his 50's. Grandfather dies of bowel cancer in his 70's. Cousin diagnosed with non hodgkin's lymphoma in his 30's. What is the likelihood of the remaining siblings in (2 brothers & 3 sisters) also being a carrier. I believe the risk of inheriting is 50% for every child born of a carrier, but what is the occurence. Given the strong family history of both paternal and maternal - Is it possible 6/6 will carry the BRAC1 (or any other cancer related gene)  
julie bee
over 6 years ago
Www.bmj
0
16

Surgery for melanoma is often delayed in Medicare patients, study finds

A fifth of US patients with melanoma being treated under the Medicare program wait more than 1.5 months before having the malignancy removed, and more than 8% wait longer than three months, a new study has found.  
feeds.bmj.com
over 4 years ago
Preview
0
17

First drug is approved under scheme that gives patients access to unlicensed medicines

The first drug to be made available to patients in the United Kingdom before it is formally licensed will be pembrolizumab, a treatment for advanced melanoma.  
feeds.bmj.com
over 4 years ago
Www.bmj
0
12

Surgery for melanoma is often delayed in Medicare patients, study finds

A fifth of US patients with melanoma being treated under the Medicare program wait more than 1.5 months before having the malignancy removed, and more than 8% wait longer than three months, a new study has found.  
feeds.bmj.com
over 4 years ago
Preview
0
9

Melanoma drug shows promise for treating advanced lung cancer

A drug approved to treat melanoma has proven effective for treating advanced nonsmall cell lung cancer in a new study - particularly for patients with high PD-L1 expression.  
medicalnewstoday.com
over 4 years ago
Preview
0
8

Provectus Biopharmaceuticals opens patient enrollment and begins phase 3 international FDA comparative clinical trial of PV-10 for melanoma

Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, enters phase 3 and has opened enrollment of patients for its phase 3 international FDA...  
medicalnewstoday.com
over 4 years ago
Preview
0
11

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Giving the two immunotherapies ipilimumab and nivolumab simultaneously yielded better treatment responses than ipilimumab alone in patients with advanced melanoma who received no prior...  
medicalnewstoday.com
over 4 years ago
Preview
0
11

Melanoma's 'safe haven' targeted for shut-down

Melanoma cells become drug resistant by using surrounding healthy cells to provide a 'safe haven' from treatment, according to new research published in Cancer Cell.  
medicalnewstoday.com
over 4 years ago
Preview
0
7

A downward trend for new cases of pediatric melanoma

Melanoma is an aggressive form of skin cancer that has been increasing in incidence in adults over the past 40 years.  
medicalnewstoday.com
over 4 years ago
Preview
0
7

Delay of surgery for melanoma common among Medicare patients

In a study that included more than 32,000 cases of melanoma among Medicare patients, approximately 1 in 5 experienced a delay of surgery that was longer than 1.  
medicalnewstoday.com
over 4 years ago
Preview
0
7

Study demonstrates new noninvasive gene expression profile test predicts melanoma risk more accurately than AJCC online predictor tool

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, has announced study results demonstrating that its DecisionDx-Melanoma™ gene expression profile...  
medicalnewstoday.com
over 4 years ago
Preview
0
10

Melanoma prognosis affected by number of tumor cells spread to sentinel lymph nodes

Cancer cell spread to the sentinel node - the lymph node to which cancer cells are most likely to spread from a primary tumor - is a risk factor for melanoma death.  
medicalnewstoday.com
over 4 years ago
Preview
0
8

Epigenomic changes play an important role during the progression of melanoma

KU Leuven researchers have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures.  
medicalnewstoday.com
over 4 years ago